2 completed. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
Follow BROMOCRIPTINE MESYLATE CAPSULES, USP 5 mg: new trials by email Literature Review of BROMOCRIPTINE MESYLATE CAPSULES, USP 5 mg trials Research Report on BROMOCRIPTINE MESYLATE CAPSULES, USP 5 mg
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Fed Study of (Parlodel®) 2.5 mg Bromocriptine Mesylate Tablets BROMOCRIPTINE MESYLATE CAPSULES, USP 5 mg, Parlodel® (bromocriptine mesylate) capsules, USP 5 mg - Healthy | Phase 1 | Completed | Mylan Pharmaceuticals Inc | 119 | 2007-05-01 | 2024-04-24 |
| Fed Study of (Parlodel®) Bromocriptine Mesylate Capsules 5 mg BROMOCRIPTINE MESYLATE CAPSULES, USP 5 mg, Parlodel® (bromocriptine mesylate) capsules, USP 5 mg - Healthy | Phase 1 | Completed | Mylan Pharmaceuticals Inc | 120 | 2007-04-01 | 2024-04-24 |
Canada (2)